References
- Rom WN, Garry SM. Miliary tuberculosis. In: Baker SK, Glassroth J, editors. Tuberculosis. 2th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 429-32
- Yoon YS, Lee HJ, Yoon HI, Yoo CG, Kim YW, Han SK, et al. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia. Int J Tuberc Lung Dis 2005;9:1215-9
- Piqueras AR, Marruecos L, Artigas A, Rodriguez C. Miliary tuberculosis and adult respiratory distress syndrome. Intensive Care Med 1987;13:175-82
- Kim JH, Jeoung CH, Kim HI, Park JH, Lee JS, Jeon GU, et al. A case report of the patient with miliary tuberculosis resulting in adult respiratory distress syndrome. Korean J Intern Med 1986;31:566-70
- Bae DS, Kim JK, Kim JA, Jeon KH, Lee JH, Shine WW, et al. A clinical study of miliary tuberculosis in adults. Tuberc Respir Dis 1984;31:108-14
- Ahn YS, Lee SM. A clinical review of acute respiratory distress syndrome (ARDS) due to miliary tuberculosis. Tuberc Respir Dis 2002;53:17-26 https://doi.org/10.4046/trd.2002.53.1.17
- Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2:S27-72 https://doi.org/10.1086/511159
- American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416 https://doi.org/10.1164/rccm.200405-644ST
- Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62 https://doi.org/10.1164/rccm.167.4.603
- Gindburg AS, Hooper N, Parrish N, Dooley KE, Dorman SE, Booth J, et al. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis 2003;37:1448-52 https://doi.org/10.1086/379328
- Dooley KE, Golub J, Goes FS, Merz WG, Sterling TR. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin Infect Dis 2002;34:1607-12 https://doi.org/10.1086/340618
- Lee HS, Kang YA, Oh JY, Lee JH, Yoo CG, Lee CT, et al. A case of pulmonary tuberculosis with delayed diagnosis due to the temporary clinical Iimprovement after use of levofloxacin and amikacin under the impression of community acquired pneumonia. Tuberc Respir Dis 2003;55:395-401 https://doi.org/10.4046/trd.2003.55.4.395
- Gaba PD, Haley C, Griffin MR, Mitchel E, Warkentin J, Holt E, et al. Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease. Arch Intern Med 2007;167:2317-22 https://doi.org/10.1001/archinte.167.21.2317